From: Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
Costs with PCV-7 vaccination, US$ | Cost savings, US$* | |||
---|---|---|---|---|
PHiD-CV vs PCV-7 | PCV-13 vs PCV-7 | PHiD-CV vs PCV-13 | ||
Vaccine and vaccine administration cost | 156,455,040 | 0 | 0 | 0 |
IPD cost | 1,217,684 | −112,966 | −137,691 | 24,726 |
Pneumonia hospitalizations cost | 3,939,050 | −104,850 | −117,264 | 12,413 |
AOM cost | 98,833,034 | −12,500,997 | −3,228,848 | −8,272,149 |
Total direct costs | 260,444,808 | −11,718,813 | −3,483,803 | −8,235,010 |